What Works For Anxiety Disorders–Anti-Anxiety Drugs
Short-term use (up to four weeks)
Our rating
Long-term use
Our rating
GAD
GAD
PTSD and ASD
PTSD and ASD
Social Phobia
Social Phobia
Panic Disorder and Agoraphobia
Panic Disorder and Agoraphobia
Specific Phobias
Specific Phobias
OCD
OCD
WHAT ARE THEY?
Anti-anxiety drugs are used mainly for …
European Commission Approves XEPLION® for Treatment of Schizophrenia
Beerse, Belgium (March 9, 2011) — Janssen-Cilag International NV today announced that XEPLION® (paliperidone palmitate), a once monthly, long-acting injectable, antipsychotic, has received approval from the European Commission …
Frequently Asked Questions about Depression
Q: What is depression?
A: Life is full of ups and downs. But when the down times last for weeks or months at a time or keep you from your regular activities, …
FDA approves Latuda to treat schizophrenia in adults
The U.S. Food and Drug Administration today approved Latuda (lurasidone HCl) tablets for the treatment of adults with schizophrenia.
Schizophrenia affects about 1 percent of the U.S. population, ages …
Withdrawal effects
How can I tell the difference between withdrawal problems and relapse?
There are three ways to tell if symptoms are the result of withdrawal, according to one expert, David Healy, who applied it to SSRIs …
Trazodone Hydrochloride 50mg Capsules
SUMMARY OF PRODUCT CHARACTERISTICS
NAME OF THE MEDICINAL PRODUCT: Trazodone Hydrochloride 50mg Capsules
QUALITATIVE AND QUANTITATIVE COMPOSITION
Trazodone Hydrochloride 50mg (For the full list of excipients, see section 6.1)
PHARMACEUTICAL FORM
Capsules Hard gelatin, size 3, green-violet coloured …
Psychotropic Medication Use among Adolescents: United States, 2005–2010
Key findings
Data from the National Health and Nutrition Examination Survey
Approximately 6.0% of U.S. adolescents aged 12–19 reported psychotropic drug use in the past month.
The use of antidepressants (3.2%) …
